Program to help in affected person entry to Surgalign’s Coflex® Interlaminar Stabilization® and SImmetry® SI Joint Fusion Methods
DEERFIELD, In poor health., July 14, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) a world medical expertise firm centered on elevating the usual of care by driving the evolution of digital well being, introduced PRIA Healthcare will function a strategic associate in assist of the lately launched Surgalign™ Affected person Entry Program.
The target of the Surgalign Affected person Entry Program is to assist sufferers notice improved entry to medical applied sciences that drive higher outcomes, such because the Firm’s Coflex Interlaminar Stabilization and SImmetry Sacroiliac (SI) Joint Fusion techniques. As a relentless advocate for sufferers, PRIA brings to the collaboration greater than 10 years of expertise partnering with MedTech firms to enhance affected person entry to the newest medical applied sciences.
Terry Wealthy, President and Chief Government Officer of Surgalign said, “Our imaginative and prescient at Surgalign is to drive optimum affected person outcomes whereas advancing the usual of backbone care. We partnered with PRIA due to their in depth expertise advocating for sufferers to obtain favorable medical protection. Finally this program will broaden affected person entry to procedures and units such because the Coflex Interlaminar Stabilization and SImmetry SI Joint Fusion techniques.”
The Coflex Interlaminar Stabilization system is a lumbar movement preservation resolution that maintains stability within the backbone after direct surgical decompression whereas preserving extra pure motion. Coflex has Degree 1 scientific knowledge from a randomized management trial used for PMA approval that has been reported within the Worldwide Journal of Backbone Surgical procedure1. Additional, the Coflex system seems in additional than 90 peer reviewed publications and has been implanted greater than 175,000 occasions globally.
The SImmetry SI Joint Fusion system is the one lateral method SI process that follows orthopedic ideas of joint decortication, bone grafting and fixation, to create the absolute best setting to realize true arthrodesis. The lately printed SImmetry EVoluSIon research (EVSI), one of many largest SI joint fusion research carried out so far, confirmed statistically vital enhancements in each ache and incapacity, together with a statistically vital discount within the variety of sufferers utilizing opioids at 12 months2.
“We stay up for seeing the constructive influence PRIA’s streamlined authorization and enchantment course of has on the challenges sufferers face to acquire medical protection for wanted care,” added Scott Durall, Chief Business Officer of Surgalign. “This partnership highlights our dedication to supporting our doctor and affected person neighborhood by educating payers on the scientific advantages of novel therapies resembling Coflex and SImmetry, that present constructive scientific outcomes for sufferers.”
1 Musacchio MJ, Lauryssen C, Davis RJ, et al. Analysis of Decompression and Interlaminar Stabilization In contrast with Decompression and Fusion for the Therapy of Lumbar Spinal Stenosis: 5-year Observe-up of a Potential, Randomized, Managed Trial. Int. J. Backbone Surg. 2016 Jan 26;10:6. Doi: 10.14444/3006. eCollection 2016. 2 Kucharzyk D, Colle Ok, Boone C, Araghi A. Medical outcomes following minimally invasive sacroiliac joint fusion with decortication: The EVoluSIon scientific research. Int. J. Backbone Surg. 2022, 16 (1) 168-175. doi: https://doi.org/10.14444/8185.
About Surgalign Holdings, Inc. Surgalign Holdings, Inc. is a world medical expertise firm dedicated to the promise of digital well being to drive transformation throughout the surgical panorama. Uniquely aligned and resourced to advance the usual of care, the corporate is constructing applied sciences physicians and different well being suppliers will look to for what is really potential for his or her sufferers. Surgalign is targeted on growing options that predictably ship superior scientific and financial outcomes. Surgalign markets merchandise all through the USA and in additional than 50 international locations worldwide via an increasing community of high unbiased distributors. Surgalign is headquartered in Deerfield, IL, with business, innovation and design facilities in San Diego, CA, Warsaw and Poznan, Poland, and Wurmlingen, Germany. Be taught extra at http://www.surgalign.com and join on LinkedIn and Twitter.
About PRIA Healthcare Since 2012, PRIA Healthcare has been a nationwide chief in reimbursement and market entry to the healthcare area all through the USA. Led by a staff of trade veterans, PRIA is dedicated to making sure the newest medical applied sciences and procedures can be found to sufferers each throughout scientific trials and thru product commercialization. PRIA diligently works to affect payers to ascertain affected person entry to life altering units, therapies, therapies, and procedures by leveraging scientific knowledge, affected person, and doctor rights.
Ahead Wanting Assertion This press launch incorporates forward-looking statements inside the which means of the Personal Securities Litigation Reform Act of 1995. These forward-looking statements are primarily based on administration’s present expectations, estimates and projections about our merchandise, firm, and trade, our administration’s beliefs, and sure assumptions made by our administration. Phrases resembling “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” and different variations of such phrases and comparable expressions are supposed to determine such forward-looking statements. These statements aren’t ensures of future efficiency and are topic to dangers and uncertainties, together with the dangers described in our public filings with the U.S. Securities and Change Fee (SEC). Our precise outcomes might differ materially from the anticipated outcomes mirrored in these forward-looking statements. Copies of the corporate’s SEC filings could also be obtained by contacting the corporate or the SEC or by visiting Surgalign’s web site at www.surgalign.com or the SEC’s web site at www.sec.gov.